BioCentury
ARTICLE | Finance

Analyst tracks

Biotech investor, banker, analyst personnel changes

October 4, 2010 7:00 AM UTC

Michael King joined Ziopharm Oncology Inc. (NASDAQ:ZIOP) as SVP of corporate development and communication. He was managing director and senior biotechnology analyst at Wedbush Securities....